FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37028811000001104: Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
46901000001111 Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
46921000001116 Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Has AMP Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Is a Alendronic acid 70mg tablets 4 tablet true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Has specific active ingredient Alendronate sodium true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alendronic acid true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Alendronic acid 70mg tablets (Mawdsley-Brooks & Company Ltd) 4 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start